Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

PANCREATIC CANCER

Endocrine–exocrine signals in obesity-associated pancreatic cancer

Obesity is a known risk factor for pancreatic cancer. Now, a new study reports that obesity accelerates early pancreatic cancer development and growth in mice through local perturbations in the pancreatic microenvironment and implicates pancreatic islet-derived cholecystokinin as a driving factor.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2020. CA Cancer J. Clin. 70, 7–30 (2020).

    Article  Google Scholar 

  2. 2.

    Rahib, L. et al. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 74, 2913–2921 (2014).

    CAS  Article  Google Scholar 

  3. 3.

    Lauby-Secretan, B. et al. Body fatness and cancer–viewpoint of the IARC Working Group. N. Engl. J. Med. 375, 794–798 (2016).

    Article  Google Scholar 

  4. 4.

    Islami, F. et al. Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States. CA Cancer J. Clin. 68, 31–54 (2018).

    Article  Google Scholar 

  5. 5.

    Murphy, N., Jenab, M. & Gunter, M. J. Adiposity and gastrointestinal cancers: epidemiology, mechanisms and future directions. Nat. Rev. Gastroenterol. Hepatol. 15, 659–670 (2018).

    CAS  Article  Google Scholar 

  6. 6.

    Chung, K. M. et al. Endocrine-exocrine signaling drives obesity-associated pancreatic ductal adenocarcinoma. Cell 181, 832–847 (2020).

    CAS  Article  Google Scholar 

  7. 7.

    Chang, H. H. et al. Incidence of pancreatic cancer is dramatically increased by a high fat, high calorie diet in KrasG12D mice. PLOS ONE 12, e0184455 (2017).

    Article  Google Scholar 

  8. 8.

    Chang, H. H. et al. Metformin decreases the incidence of pancreatic ductal adenocarcinoma promoted by diet-induced obesity in the conditional KrasG12D mouse model. Sci. Rep. 8, 5899 (2018).

    Article  Google Scholar 

  9. 9.

    Nadella, S. et al. Dietary fat stimulates pancreatic cancer growth and promotes fibrosis of the tumor microenvironment through the cholecystokinin receptor. Am. J. Physiol. Gastrointest. Liver Physiol. 315, G699–G712 (2018).

    CAS  Article  Google Scholar 

  10. 10.

    Storz, P. Acinar cell plasticity and development of pancreatic ductal adenocarcinoma. Nat. Rev. Gastroenterol. Hepatol. 14, 296–304 (2017).

    CAS  Article  Google Scholar 

Download references

Acknowledgements

The laboratory of the author is supported by the National Cancer Institute (P01CA236585).

Author information

Affiliations

Authors

Corresponding author

Correspondence to Guido Eibl.

Ethics declarations

Competing interests

The author declares no competing interests.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Eibl, G. Endocrine–exocrine signals in obesity-associated pancreatic cancer. Nat Rev Gastroenterol Hepatol 17, 455–456 (2020). https://doi.org/10.1038/s41575-020-0324-6

Download citation

Further reading

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing